Epilepsy in the Elderly

Hesdorffer, 2011, Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota, Neurology, 76, 23, 10.1212/WNL.0b013e318204a36a Hauser, 1992, Seizure disorders: the changes with age, Epilepsia, 33, S6, 10.1111/j.1528-1157.1992.tb06222.x Hauser, 1993, Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984, Epilepsia, 34, 453, 10.1111/j.1528-1157.1993.tb02586.x Pugh, 2007, The impact of epilepsy on older veterans, Int Rev Neurobiol, 81, 221, 10.1016/S0074-7742(06)81014-7 McLaughlin, 2008, Stigma, seizure frequency and quality of life: the impact of epilepsy in late adulthood, Seizure, 17, 281, 10.1016/j.seizure.2007.09.001 McLaughlin, 2010, The impact of depression, seizure variables and locus of control on health related quality of life in a community dwelling sample of older adults, Seizure, 19, 232, 10.1016/j.seizure.2010.02.008 Bergey, 2005, Minimizing misdiagnoses in epilepsy in the elderly, Geriatrics, Suppl., 7 Stephen, 2000, Epilepsy in elderly people, Lancet, 355, 1441, 10.1016/S0140-6736(00)02149-8 Godfrey, 1989, Misleading presentation of epilepsy in elderly people, Age Ageing, 18, 17, 10.1093/ageing/18.1.17 Collins, 2006, Elders with Epilepsy, Med Clin North Am, 90, 945, 10.1016/j.mcna.2006.06.002 Ramsay, 2004, Special considerations in treating the elderly patient with epilepsy, Neurology, 62, S24, 10.1212/WNL.62.5_suppl_2.S24 Alroughani, 2009, Non-convulsive status epilepticus; the rate of occurrence in a general hospital, Seizure, 18, 38, 10.1016/j.seizure.2008.06.013 Drury, 1998, Interictal epileptiform activity in elderly patients with epilepsy, Electroencephalogr Clin Neurophysiol, 106, 369, 10.1016/S0013-4694(97)00158-2 Kipervasser, 2007, Video-EEG monitoring of paroxysmal events in the elderly, Acta Neurol Scand, 116, 221, 10.1111/j.1600-0404.2007.00888.x Dupont, 2010, Seizures in the elderly: Development and validation of a diagnostic algorithm, Epilepsy Res, 89, 339, 10.1016/j.eplepsyres.2010.02.008 Bergey, 2004, Initial treatment of epilepsy: special issues in treating the elderly, Neurology, 63, S40, 10.1212/WNL.63.10_suppl_4.S40 Cloyd, 2006, Epidemiological and medical aspects of epilepsy in the elderly, Epilepsy Res, 68, S39, 10.1016/j.eplepsyres.2005.07.016 Towne, 1994, Determinants of mortality in status epilepticus, Epilepsia, 35, 27, 10.1111/j.1528-1157.1994.tb02908.x So, 1996, Population-based study of seizure disorders after cerebral infarction, Neurology, 46, 350, 10.1212/WNL.46.2.350 Hesdorffer, 1996, Dementia and adult-onset unprovoked seizures, Neurology, 46, 727, 10.1212/WNL.46.3.727 Amatniek, 2006, Incidence and predictors of seizures in patients with Alzheimer's disease, Epilepsia, 47, 867, 10.1111/j.1528-1167.2006.00554.x Wang, 2011, The Clinical Presentation, Diagnosis, Treatment, and Outcome of Encephalitis: Five Years of Experience at a Medical Center in Northern Taiwan, Int J Gerontol, 5, 9, 10.1016/j.ijge.2011.01.002 Sirven, 2005, Diagnosing epilepsy in older adults: what does it mean for the primary care physician?, Geriatrics, 60, 30 Berg, 1991, The risk of seizure recurrence following a first unprovoked seizure: a quantitative review, Neurology, 41, 965, 10.1212/WNL.41.7.965 Musicco, 1997, Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group), Neurology, 49, 991, 10.1212/WNL.49.4.991 Hesdorffer, 2009, Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure, Epilepsia, 50, 1102, 10.1111/j.1528-1167.2008.01945.x Miller, 2007, Treatment strategies after a single seizure: rationale for immediate versus deferred treatment, CNS Drugs, 21, 89, 10.2165/00023210-200721020-00001 Marson, 2008, When to start antiepileptic drug treatment and with what evidence?, Epilepsia, 49, 3, 10.1111/j.1528-1167.2008.01920.x Kim, 2006, Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial, Lancet Neurology, 5, 317, 10.1016/S1474-4422(06)70383-0 Kwan, 2000, Early identification of refractory epilepsy, N Engl J Med, 342, 314, 10.1056/NEJM200002033420503 Stephen, 2006, Pharmacological outcomes in older people with newly diagnosed epilepsy, Epilepsy Behav, 8, 434, 10.1016/j.yebeh.2005.11.007 Brodie, 2007, Outcomes in elderly patients with newly diagnosed and treated epilepsy, Int Rev Neurobiol, 81, 253, 10.1016/S0074-7742(06)81016-0 Gidal, 2006, Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs, Epilepsy Res, 68, S65, 10.1016/j.eplepsyres.2005.07.018 Battino, 2004, Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data, Epilepsy Res, 59, 155, 10.1016/j.eplepsyres.2004.04.006 Greenblatt, 1979, Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program, J Am Geriatr Soc, 27, 20, 10.1111/j.1532-5415.1979.tb01715.x Ahn, 2008, Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy, Neurology, 71, 38, 10.1212/01.wnl.0000316392.55784.57 Bauer, 1982, Age and phenytoin kinetics in adult epileptics, Clin Pharmacol Ther, 31, 301, 10.1038/clpt.1982.37 Bauer, 1985, Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults, Clin Pharmacol Ther, 37, 697, 10.1038/clpt.1985.116 Birnbaum, 2003, Variability of total phenytoin serum concentrations within elderly nursing home residents, Neurology, 60, 555, 10.1212/01.WNL.0000052997.43492.E0 Perucca, 2006, Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age, Clin Pharmacokinet, 45, 351, 10.2165/00003088-200645040-00002 Birbeck, 2002, Seizure reduction and quality of life improvements in people with epilepsy, Epilepsia, 43, 535, 10.1046/j.1528-1157.2002.32201.x Bill, 1997, A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy, Epilepsy Res, 27, 195, 10.1016/S0920-1211(97)00024-7 Christe, 1997, A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy, Epilepsy Res, 26, 451, 10.1016/S0920-1211(96)01013-3 Dam, 1989, A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy, Epilepsy Res, 3, 70, 10.1016/0920-1211(89)90070-3 French, 2004, Neurology, 62, 1252, 10.1212/01.WNL.0000123693.82339.FC 2004 Pugh, 2004, Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy, J Am Geriatr Soc, 52, 417, 10.1111/j.1532-5415.2004.52115.x Brodie, 1999, Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group, Epilepsy Res, 37, 81, 10.1016/S0920-1211(99)00039-X Rowan, 2005, New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine, Neurology, 64, 1868, 10.1212/01.WNL.0000167384.68207.3E Glauser, 2006, ILAE Treatment Guidelines: evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes, Epilepsia, 47, 1094, 10.1111/j.1528-1167.2006.00585.x Saetre, 2007, An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly, Epilepsia, 48, 1292, 10.1111/j.1528-1167.2007.01128.x Ramsay, 1994, Effect of age on epilepsy and its treatment: results from the VA Cooperative Study [abstract], Epilepsia, 35, 91 Gurwitz, 2003, Incidence and preventability of adverse drug events among older persons in the ambulatory setting, J Am Med Assoc, 289, 1107, 10.1001/jama.289.9.1107 Pugh, 2008, Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000–2004, Neurology, 70, 2171, 10.1212/01.wnl.0000313157.15089.e6 Pugh, 2006, Prescribing antiepileptics for the elderly - Differences between guideline recommendations and clinical practice, Drugs Aging, 23, 861, 10.2165/00002512-200623110-00002 Kutluay, 2003, Safety and tolerability of oxcarbazepine in elderly patients with epilepsy, Epilepsy Behav, 4, 175, 10.1016/S1525-5050(03)00037-4 Dogan, 2008, Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy, Epilepsy Behav, 13, 156, 10.1016/j.yebeh.2008.02.001 Ferrendelli, 2003, Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial*1, Epilepsy Behav, 4, 702, 10.1016/j.yebeh.2003.09.007 Alsaadi, 2004, Levetiracetam monotherapy for elderly patients with epilepsy, Seizure, 13, 58, 10.1016/S1059-1311(03)00070-0 Belcastro, 2008, Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study, Epilepsy Res, 82, 223, 10.1016/j.eplepsyres.2008.08.008 Belcastro, 2007, Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study, Eur J Neurol, 14, 1176, 10.1111/j.1468-1331.2007.01907.x Groselj, 2005, Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy, Acta Neurol Scand, 112, 144, 10.1111/j.1600-0404.2005.00469.x Ramsay, 2008, Topiramate in older patients with partial-onset seizures: A pilot double-blind, dose-comparison study, Epilepsia, 49, 1180, 10.1111/j.1528-1167.2008.01584.x Ettinger, 2009, Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy, Epilepsy Behav, 14, 324, 10.1016/j.yebeh.2008.10.021 Faught, 2008, Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study, Neurology, 71, 1572, 10.1212/01.wnl.0000319693.10338.b9 Pugh, 2010, Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications, J Am Geriatr Soc, 58, 465, 10.1111/j.1532-5415.2010.02732.x Diaz, 2008, Antiepileptic drug interactions, Neurologist, 14, S55, 10.1097/01.nrl.0000340792.61037.40 Ryvlin, 2006, Optimizing therapy of seizures in stroke patients, Neurology, 67, S3, 10.1212/WNL.67.12_suppl_4.S3 Mintzer, 2009, Should enzyme-inducing antiepileptic drugs be considered first-line agents?, Epilepsia, 50, 42, 10.1111/j.1528-1167.2009.02235.x Boggs, 2011, Seizure management in the setting of hepatic disease, Curr Treat Options Neurol, 13, 333, 10.1007/s11940-011-0129-6 Lacerda, 2006, Optimizing therapy of seizures in patients with renal or hepatic dysfunction, Neurology, 67, S28, 10.1212/WNL.67.12_suppl_4.S28